Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 03 Jun 2025 for bluebird bio, Inc..
Filing timeline
BuySaleElisabeth Leiderman
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Elisabeth Leiderman: trading record in brief
All filings by Elisabeth Leiderman on record concern bluebird bio, Inc., in the capacity of board member. The record holds 8 filings, for trades running from 15 October 2021 to 2 June 2025.
No open-market purchase appears, only 1 sale worth €6,591. Besides market trades, the filings include 4 share grants.
On 3 June 2025 came the latest disclosure, a transaction in bluebird bio, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Elisabeth Leiderman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
1,112 sharesCommon StockSEC:0000950170-25-081135:0
24,900 shares0Common StockSEC:0001562180-24-007604:0
10,790 shares0Common StockSEC:0001562180-23-005351:0
1,004 shares@ US$6.4643100.0% of flowCommon StockSEC:0001562180-23-002662:0
3,109 shares0Common StockSEC:0001562180-22-005336:0
9,361 shares0Common StockSEC:0001628280-21-023460:0
4,663 shares0Common StockSEC:0001562180-21-006578:0
7 of 7 declarations
